Cathelicidin LL-37 in Health and Diseases of the Oral Cavity

被引:27
|
作者
Tokajuk, Joanna [1 ,2 ]
Deptula, Piotr [1 ]
Piktel, Ewelina [3 ]
Daniluk, Tamara [1 ]
Chmielewska, Sylwia [1 ]
Wollny, Tomasz [4 ]
Wolak, Przemyslaw [5 ]
Fiedoruk, Krzysztof [1 ]
Bucki, Robert [1 ]
机构
[1] Med Univ Bialystok, Dept Med Microbiol & Nanobiomed Engn, Mickiewicza 2C, PL-15222 Bialystok, Poland
[2] Dent & Med Tokajuk, Zelazna 9-7, PL-15297 Bialystok, Poland
[3] Med Univ Bialystok, Independent Lab Nanomed, Mickiewicza 2B, PL-15222 Bialystok, Poland
[4] Holy Cross Oncol Ctr Kielce, Artwinskiego 3, PL-25734 Kielce, Poland
[5] Jan Kochanowski Univ Kielce, Coll Med, Inst Med Sci, IX Wiekow Kielc 19A, PL-25317 Kielce, Poland
关键词
oarl cavity; human cathelicidin; antimicrobial peptides; immunomodulation; ANTIMICROBIAL PEPTIDE LL-37; GINGIVAL CREVICULAR FLUID; PORPHYROMONAS-GINGIVALIS; ANTIBACTERIAL ACTIVITY; GROWTH-FACTOR; SALIVARY CONCENTRATION; EPITHELIAL-CELLS; INNATE IMMUNITY; MYELOID CELLS; CANCER-CELLS;
D O I
10.3390/biomedicines10051086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interaction might lead to the development of various oral pathologies and systemic diseases. Two important players in maintaining oral health or developing oral pathology are the oral microbiota and various immune molecules that are involved in controlling its quantitative and qualitative composition. The LL-37 peptide is an important molecule that upon release from human cathelicidin (hCAP-18) can directly perform antimicrobial action after insertion into surface structures of microorganisms and immunomodulatory function as an agonist of different cell membrane receptors. Oral LL-37 expression is an important factor in oral homeostasis that maintains the physiological microbiota but is also involved in the development of oral dysbiosis, infectious diseases (including viral, bacterial, and fungal infections), autoimmune diseases, and oral carcinomas. This peptide has also been proposed as a marker of inflammation severity and treatment outcome.
引用
收藏
页数:30
相关论文
共 50 条
  • [21] Multifunctional roles of human cathelicidin (LL-37) at the ocular surface
    Huang, Ling C.
    Petkova, Tihomira D.
    Reins, Rose Y.
    Proske, Rita J.
    McDermott, Alison M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (06) : 2369 - 2380
  • [22] Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity
    Otte, Jan-Michel
    Zdebik, Anna-Elisabeth
    Brand, Stephan
    Chromik, Ansgar M.
    Strauss, Sarah
    Schmitz, Frank
    Steinstraesser, Lars
    Schmidt, Wolfgang E.
    REGULATORY PEPTIDES, 2009, 156 (1-3) : 104 - 117
  • [23] Modulation of exogenous antibiotic activity by host cathelicidin LL-37
    Leszczynska, Katarzyna
    Namiot, Andrzej
    Janmey, Paul A.
    Bucki, Robert
    APMIS, 2010, 118 (11) : 830 - 836
  • [24] Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide
    Golec, Marcin
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2007, 14 (01) : 1 - 4
  • [25] Cathelicidin LL-37 - A central factor in the pathogenesis of inflammatory dermatoses?
    Schauber, J.
    Ruzicka, T.
    Rupec, R. A.
    HAUTARZT, 2008, 59 (01): : 72 - 74
  • [26] Study of cathelicidin (LL-37) immunoexpression in the skin of vitiligo patients
    Elgarhy, Lamia Hamouda
    Ramadan, Basma Ramadan Refaey
    Sallam, Fersan Abd Allah
    Iskandarani, Dalya Ayman
    Hewedy, El-Sayed Shaaban
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [27] Human cathelicidin LL-37 prevents bacterial biofilm formation
    Jacobsen, Andreas S.
    Jenssen, Havard
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (12) : 1587 - 1599
  • [28] Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases
    Schauber, Juergen
    Rieger, Daniel
    Weiler, Frank
    Wehkamp, Jan
    Eck, Matthias
    Fellermann, Klaus
    Scheppach, Wolfgang
    Gallo, Richard L.
    Stange, Eduard F.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (06) : 615 - 621
  • [29] The role of the microenvironment protein cathelicidin LL-37 in pancreatic ductal adenocarcinoma
    Sainz, Bruno, Jr.
    Frias, Javier
    Cioffi, Michele
    Alcala, Sonia
    Heeschen, Christopher
    CANCER RESEARCH, 2013, 73
  • [30] LL-37, the only human member of the cathelicidin family of antimicrobial peptides
    Durr, Ulrich H. N.
    Sudheendra, U. S.
    Ramamoorthy, Ayyalusamy
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (09): : 1408 - 1425